8
NEWS
New Biolinq Shine needle-free sensor for T2D
The FDA has cleared a new glucose
sensor called the Biolinq Shine, a
needle-free option for people with
Type 2 diabetes who do not use
insulin.
The Shine is an adhesive patch
about the size of a US quarter (or
British 10p piece) that uses a small,
color-coded LED indicator, rather
than a numeric display, to show
whether glucose is in, above, or
below range.
Cleared for adults ages 22 and up,
it also tracks other measures that
may support glucose management,
such as sleep and activity, with details
viewable in a mobile app. While it is
not as precise as the numerical data
that a CGM offers, new approaches
such as the Biolinq Shine may offer
people with Type 2 diabetes not on
insulin an easy, needle-free way to
monitor their blood sugar.
www.biolinq.com
Why early detection of
Type 1 diabetes matters
Changing the story: Why early
detection of Type 1 diabetes must
become the norm says Karen
Addinngton of charity Breakthrough
T1D. She says, "Too many people in the
UK are introduced to Type 1 diabetes
(T1D) in the worst possible way -
through a medical emergency.
"There are many dreadful stories
of the panic and crisis that people
feel when they are diagnosed late
with Type 1 diabetes. At worst, there
is the terrifying reality of diabetic
ketoacidosis (DKA), which can mean
coma, organ failure, a traumatic
hospital stay and - if not treated
quickly - can be fatal.
"Thanks to research funded by
Breakthrough T1D, there are now have
ways to detect Type 1 diabetes before
symptoms appear. The charity has
now published a white paper explains
why spotting T1D in its earliest
stages is so important, shows how
early detection can save lives, reduce
trauma and give people a better
chance of living well with Type 1 from
day one. It also sets out what needs
to happen next, including raising
awareness, making screening for
early detection more widely available
and ensuring people can access new
treatments.
Studies show that early detection
screening can almost eli"minate
diagnosis during DKA. It would
mean fewer parents blindsided by a
diagnosis they never saw coming. It
would give people a softer landing
into life with Type 1 diabetes - not
through panic and emergency, but
through preparation, support and
understanding."
To find out more, CLICK HERE.
SKINCARE MATTERS! Take our survey in associaton with CliniMed to tell us of
your experience and wishes. Free sample packs on offer.
To take part click HERE.